Edward D. Huey, MD

Expertise in: 
Neuropsychiatry
Board Certifications: 
Psychiatry
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Neuropsychiatry, Psychiatry, Adjustment Disorder, Anxiety, Generalized Anxiety Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Social Anxiety Disorder, Bipolar Disorder, Depression, Insomnia, Mental Health, Mood Disorders, Obsessive Compulsive Disorder (OCD), Panic Disorder, Psychopharmacology, Psychosis, Psychotherapy

Academic Appointments

  • Associate Professor of Psychiatry and Neurology (in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain)

Edward (Ted) Huey, M.D. is an Associate Professor of Psychiatry and Neurology at Columbia University College of Physicians and Surgeons (New York, NY), in the Departments of Psychiatry (Division of Geriatric Psychiatry) and Neurology (Division of Aging and Dementia), the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, and the Gertrude H. Sergievsky Center.

Dr. Huey obtained his B.A. in psychology from Yale University. He received his medical degree from the Stanford University School of Medicine in 1999. He completed an internship and a residency in Adult Psychiatry at the Stanford University Medical Center in Stanford, California. He was elected to be the chief resident for the program in his final year of residency. He then completed a clinical research fellowship and was an Assistant Clinical Investigator in the Cognitive Neuroscience Section of the National Institute of Neurological Disorders and Stroke in the National Institutes of Health in Bethesda, MD. He was then the Director of Clinical Science of the Litwin-Zucker Research Center for the Study of Alzheimer's Disease and Memory Disorders of the Feinstein Institute, North-Shore / Long Island Jewish Medical Center. He joined the Columbia University faculty in 2010.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-6939

Location(s)

CUMC/Neurological Institute of New York
710 West 168th Street
New York, NY 10032
New Patient Appointments:
212-305-9758
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Stanford University School of Medicine
  • Residency: Stanford University Medical Center
  • Fellowship: National Institute of Mental Health

Board Certifications

  • Psychiatry

Research

Dr. Huey is interested in the interface between psychiatry and neurology -- the behavioral, cognitive and emotional effects of neurological disorders and what we can learn about psychiatric disorders from patients with neuroanatomic and genetic disorders.

Dr. Huey's research has focused on patients with frontal lobe disorders, including patients with frontotemporal lobar degeneration (FTLD) and related disorders such as corticobasal syndrome and ALS, and brain injury. He studies the genetics of FTLD and is interested in the range of behavioral and emotional symptoms associated with mutations that cause FTLD. He also uses imaging in patients with frontal lobe disorders to explore the role of the frontal lobes in behavior and emotion, and the development of psychiatric disorders including mood disorders, PTSD, and OCD. A third interest is in the role of the dopamine system in the pathogenesis and treatment of the symptoms of FTLD. He is the recipient of a NIH / NINDS Pathway to Independence Award to research novel medication treatments and imaging biomarkers for FTLD.

Research Interests

  • Behavioral, cognitive and emotional effects of neurological disorders
  • frontotemporal dementia
  • FTD
  • FTLD
  • Huntington's disease
  • HD
  • Pick's disease
  • Frontotemporal lobar degeneration
  • Progressive Supranuclear Palsy
  • PSP
  • Corticobasal syndrome
  • CBS
  • Corticobasal ganglionic degeneration
  • CBD
  • CBGD
  • Neuropsychiatry

Grants

NEUROANATOMICAL ASSOCIATIONS WITH THE FACTOR STRUCTURE UNDERLYING NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER S DISEASE (Federal Gov)

Sep 30 2018 - May 31 2023

ANTI-VIRAL THERAPY IN ALZHEIMER S DISEASE (Federal Gov)

Sep 15 2017 - May 31 2022

PREDICTORS OF SEVERITY IN ALZHEIMER S DISEASE (Federal Gov)

Jun 15 2017 - May 31 2022

TASK-SPECIFIC AND PERSON-SPECIFIC FACTORS RELATED TO SUBJECTIVECOGNITIVE DECLINE (Federal Gov)

Aug 1 2017 - Apr 30 2022

COGNITIVE TRAINING AND NEUROPLASTICITY IN MILD COGNITIVE IMPAIRMENT (Federal Gov)

Jul 15 2017 - Apr 30 2022

IMAGING OF COGNITION, LEARNING AND MEMORY IN AGING (Federal Gov)

May 1 2017 - Mar 31 2022

APATHY AND NEGATIVE SYMPTOMS IN ALZHEIMER S DISEASE: INVESTIGATION OF THE PROLINE*COMT INTERACTION FOR SYMPTOM TARGETING TO POSITIVELY IMPACT QUALITY OF LIFE (Federal Gov)

Sep 15 2018 - Sep 14 2021

EXPLORING COGNITIVE AGING USING REFERENCE ABILITY NEURAL NETWORKS (Federal Gov)

Aug 1 2016 - Jun 30 2021

APATHY IN ALZHEIMER S DISEASE: INVESTIGATION OF THE INTERACTION BETWEEN PROLINE AND COMT FOR TREATMENT TARGETING TO POSITIVELY IMPACT QUALITY OF LIFE (Federal Gov)

Aug 15 2018 - Apr 30 2020

EXAMINATION OF THE EARLIEST SYMPTOMS AND BIOMARKERS OF FTLD MAPT CARRIERS (Federal Gov)

Sep 21 2012 - Jul 31 2019

CLINICAL-PATHOLOGICAL STUDY OF COGNITIVE IMPAIRMENT IN ESSENTIAL TREMOR (Federal Gov)

Jul 1 2015 - May 31 2019

LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) (Federal Gov)

Sep 30 2014 - May 31 2019

CLINICAL-PATHOLOGICAL STUDY OF COGNITIVE IMPAIRMENT IN ESSENTIAL TREMOR (Federal Gov)

Jun 1 2014 - May 31 2019

OLFACTORY DEFICITS AND DONEPEZIL TREATMENT IN COGNITIVELY IMPAIRED ELDERLY (Federal Gov)

Jun 15 2013 - May 31 2019

THE FOUR REPEAT TAUOPATHY NEUROIMAGING INITIATIVE (Federal Gov)

Mar 1 2017 - Feb 28 2018

LOW-DOSE LITHIUM FOR THE TREATMENT OF BEHAVIORAL SYMPTOMS IN FTD (Private)

Apr 1 2016 - Mar 31 2017

CLINICAL-PATHOLOGICAL STUDY OF COGNITIVE IMPAIRMENT IN ESSENTIAL TREMOR (Federal Gov)

Jul 1 2015 - May 31 2016

BDNF VAL66MET GENOTYPE AND AGE: IMPACT ON BIOMARKERS AND EXERCISE-BASED TREATMENT (Federal Gov)

Sep 15 2011 - May 31 2016

THE FRONTOTEMPORAL LOBAR DEGENERATION CLINICAL RESEARCH CONSORTIUM (Federal Gov)

Oct 1 2014 - Jul 31 2015

INVESTIGATION OF THE DOPAMINE SYSTEM IN FRONTOTEMPORAL DEMENTIA (Federal Gov)

May 1 2009 - Apr 30 2014

Selected Publications

  • Huey ED, Goveia EN, Paviol S, Pardini M, Krueger F, Zamboni G, Tierney MC, Wassermann EM, Grafman J: Executive dysfunction in frontotemporal dementia and corticobasal syndrome.& Neurology 2009;72(5): 453-9
  • Huey ED, Pardini M, Cavanagh A, Wassermann EM, Kapogiannis D, Spina S, Ghetti B, Grafman J: Ideomotor apraxia is associated with frontal grey matter volume loss in corticobasal syndrome. Archives of Neurology 2009;66(10): 1274-80
  • Koenigs M, Huey ED, Raymont V, Cheon B, Solomon J, Wassermann EM, Grafman, J: Focal brain damage protects against post-traumatic stress disorder in combat veterans. Nature Neuroscience 2008;11: 232-7
  • Huey ED, Grafman J, Wassermann EM, Pietrini P, Tierney MC, Ghetti B, Spina S, Baker M, Hutton M, Elder JW, Berger SL, Heflin KA, Hardy J, Momeni P: Characteristics of frontotemporal dementia patients with a Progranulin mutation. Annals of Neurology 2006;60(3): 374-380
  • Huey ED, Zahn R, Krueger F, Moll J, Kapogiannis D, Wassermann EM, Grafman J: A psychological and neuroanatomical model of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences 2008;Nov: 390-408